vs
Broadway Financial Corp（BYFC）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Broadway Financial Corp的季度营收约是Protalix BioTherapeutics, Inc.的1.0倍（$9.4M vs $9.1M），Broadway Financial Corp净利率更高（1934.0% vs -60.3%，领先1994.3%），Broadway Financial Corp同比增速更快（10.1% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-13.0K），过去两年Broadway Financial Corp的营收复合增速更高（9.7% vs -6.7%）
Virtu Financial是一家美国高频交易企业，该公司于2015年在纳斯达克完成上市，在全球金融高频交易领域开展业务。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
BYFC vs PLX — 直观对比
营收规模更大
BYFC
是对方的1.0倍
$9.1M
营收增速更快
BYFC
高出60.0%
-49.9%
净利率更高
BYFC
高出1994.3%
-60.3%
自由现金流更多
PLX
多$1.6M
$-13.0K
两年增速更快
BYFC
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.4M | $9.1M |
| 净利润 | $1.0M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | — | -51.1% |
| 净利率 | 1934.0% | -60.3% |
| 营收同比 | 10.1% | -49.9% |
| 净利润同比 | -21.8% | -184.8% |
| 每股收益（稀释后） | $0.02 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BYFCPLX
| Q4 25 | $9.4M | $9.1M | ||
| Q3 25 | $9.0M | $17.9M | ||
| Q2 25 | $8.1M | $15.7M | ||
| Q1 25 | $8.3M | $10.1M | ||
| Q4 24 | $8.6M | $18.2M | ||
| Q3 24 | $8.7M | $18.0M | ||
| Q2 24 | $8.2M | $13.5M | ||
| Q1 24 | $7.8M | — |
净利润BYFCPLX
| Q4 25 | $1.0M | $-5.5M | ||
| Q3 25 | $-23.9M | $2.4M | ||
| Q2 25 | $752.0K | $164.0K | ||
| Q1 25 | $-2.7M | $-3.6M | ||
| Q4 24 | $1.3M | $6.5M | ||
| Q3 24 | $516.0K | $3.2M | ||
| Q2 24 | $256.0K | $-2.2M | ||
| Q1 24 | $-154.0K | — |
毛利率BYFCPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率BYFCPLX
| Q4 25 | — | -51.1% | ||
| Q3 25 | -256.2% | 11.9% | ||
| Q2 25 | 12.8% | 7.5% | ||
| Q1 25 | -45.3% | -41.0% | ||
| Q4 24 | 21.7% | 39.6% | ||
| Q3 24 | 8.5% | 22.2% | ||
| Q2 24 | 4.8% | -18.0% | ||
| Q1 24 | -2.9% | — |
净利率BYFCPLX
| Q4 25 | 1934.0% | -60.3% | ||
| Q3 25 | -264.2% | 13.2% | ||
| Q2 25 | 9.3% | 1.0% | ||
| Q1 25 | -32.3% | -35.8% | ||
| Q4 24 | 15.3% | 35.6% | ||
| Q3 24 | 5.9% | 18.0% | ||
| Q2 24 | 3.1% | -16.4% | ||
| Q1 24 | -2.0% | — |
每股收益（稀释后）BYFCPLX
| Q4 25 | $0.02 | $-0.06 | ||
| Q3 25 | $-2.86 | $0.03 | ||
| Q2 25 | $0.00 | $0.00 | ||
| Q1 25 | $-0.39 | $-0.05 | ||
| Q4 24 | $0.07 | $0.10 | ||
| Q3 24 | $-0.03 | $0.03 | ||
| Q2 24 | $0.02 | $-0.03 | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.5M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $262.8M | $48.2M |
| 总资产 | $1.3B | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BYFCPLX
| Q4 25 | $10.5M | $14.7M | ||
| Q3 25 | $19.7M | $13.6M | ||
| Q2 25 | $29.5M | $17.9M | ||
| Q1 25 | $15.8M | $19.5M | ||
| Q4 24 | $61.4M | $19.8M | ||
| Q3 24 | $97.1M | $27.4M | ||
| Q2 24 | $89.8M | $23.4M | ||
| Q1 24 | $67.1M | — |
股东权益BYFCPLX
| Q4 25 | $262.8M | $48.2M | ||
| Q3 25 | $261.7M | $52.9M | ||
| Q2 25 | $284.7M | $49.9M | ||
| Q1 25 | $283.6M | $45.2M | ||
| Q4 24 | $285.0M | $43.2M | ||
| Q3 24 | $286.2M | $32.4M | ||
| Q2 24 | $282.1M | $28.6M | ||
| Q1 24 | $281.1M | — |
总资产BYFCPLX
| Q4 25 | $1.3B | $82.3M | ||
| Q3 25 | $1.3B | $82.3M | ||
| Q2 25 | $1.2B | $78.5M | ||
| Q1 25 | $1.3B | $73.9M | ||
| Q4 24 | $1.3B | $73.4M | ||
| Q3 24 | $1.4B | $61.6M | ||
| Q2 24 | $1.4B | $91.5M | ||
| Q1 24 | $1.4B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-13.0K | $1.6M |
| 自由现金流率自由现金流/营收 | -0.1% | 17.8% |
| 资本支出强度资本支出/营收 | 2.6% | 4.4% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | $2.3M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流BYFCPLX
| Q4 25 | $230.0K | $2.0M | ||
| Q3 25 | $3.8M | $-3.7M | ||
| Q2 25 | $3.0M | $-5.2M | ||
| Q1 25 | $-4.3M | $-5.1M | ||
| Q4 24 | $1.4M | $4.0M | ||
| Q3 24 | $6.1M | $4.1M | ||
| Q2 24 | $9.8M | $-3.6M | ||
| Q1 24 | $-11.7M | — |
自由现金流BYFCPLX
| Q4 25 | $-13.0K | $1.6M | ||
| Q3 25 | $3.7M | $-4.2M | ||
| Q2 25 | $3.0M | $-5.7M | ||
| Q1 25 | $-4.4M | $-5.4M | ||
| Q4 24 | $1.3M | $3.6M | ||
| Q3 24 | $6.1M | $4.0M | ||
| Q2 24 | $9.7M | $-3.8M | ||
| Q1 24 | $-11.7M | — |
自由现金流率BYFCPLX
| Q4 25 | -0.1% | 17.8% | ||
| Q3 25 | 41.1% | -23.7% | ||
| Q2 25 | 37.0% | -36.2% | ||
| Q1 25 | -52.4% | -53.0% | ||
| Q4 24 | 14.7% | 19.6% | ||
| Q3 24 | 69.6% | 22.4% | ||
| Q2 24 | 118.9% | -28.1% | ||
| Q1 24 | -149.7% | — |
资本支出强度BYFCPLX
| Q4 25 | 2.6% | 4.4% | ||
| Q3 25 | 1.2% | 2.8% | ||
| Q2 25 | 0.2% | 2.8% | ||
| Q1 25 | 0.2% | 3.0% | ||
| Q4 24 | 1.6% | 2.3% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.5% | 1.3% | ||
| Q1 24 | 0.7% | — |
现金转化率BYFCPLX
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | 4.00× | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.06× | 0.61× | ||
| Q3 24 | 11.85× | 1.27× | ||
| Q2 24 | 38.21× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BYFC
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
